
Gerry Hanna Highlights a Study on Tumor Control and Immune Activation with Palliative Irradiation and ATR Inhibition
Gerry Hanna, Marie Curie Chair of Clinical Oncology at Trinity College Dublin, posted on X about recent paper by Magnus T. Dillon et al., published in Nature Communications.
“Thanks to Hegi Fiona for flagging Peter Mac Radiation Oncology fellow Magnus Dillon’s paper on the PATRIOT study led by The ICR’s Kevin Harrington.
Superb science and highly encouraging responses
Of note High T and NK cell activation in peripheral blood.”
Title: Tumor control and immune activation through palliative irradiation and ATR inhibition, PATRIOT Part C: a phase Ib trial
Authors: Magnus T. Dillon, Emmanuel C. Patin, Kabir Mohammed, Jeane Guevara, Simon A. Smith, Emma Dean, Heba Soliman, Pablo Nenclares, Motoko Ryugenji, Davina Northcote, Neel Shah, Lorna Grove, Christopher J. Lord, Stephen Pettit, Matt Tall, Karen E. Swales, Udai Banerji, Alan A. Melcher, Mark Saunders, Martin D. Forster, Kevin J. Harrington
More posts featuring Gerry Hanna on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023